Li Zhang

7.8k total citations · 2 hit papers
221 papers, 6.4k citations indexed

About

Li Zhang is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Li Zhang has authored 221 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Molecular Biology, 39 papers in Oncology and 27 papers in Plant Science. Recurrent topics in Li Zhang's work include Ginseng Biological Effects and Applications (27 papers), Glycosylation and Glycoproteins Research (18 papers) and Lung Cancer Treatments and Mutations (17 papers). Li Zhang is often cited by papers focused on Ginseng Biological Effects and Applications (27 papers), Glycosylation and Glycoproteins Research (18 papers) and Lung Cancer Treatments and Mutations (17 papers). Li Zhang collaborates with scholars based in China, Hong Kong and United States. Li Zhang's co-authors include Guochen Jia, Valery V. Fokin, Ian D. Williams, Peng Xue, Xinguo Chen, K. Barry Sharpless, Zhenyang Lin, Lars K. Rasmussen, Sridhar Narayan and Haitao Zhao and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Li Zhang

210 papers receiving 6.3k citations

Hit Papers

Ruthenium-Catalyzed Cycloaddition of Alkynes and Organic ... 2005 2026 2012 2019 2005 2008 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Zhang China 41 3.3k 2.1k 759 537 491 221 6.4k
Lihong Hu China 47 4.2k 1.3× 2.2k 1.0× 621 0.8× 621 1.2× 1.2k 2.5× 345 8.5k
Chung Yeng Looi Malaysia 38 2.2k 0.7× 683 0.3× 876 1.2× 547 1.0× 438 0.9× 111 6.0k
Miguel López‐Lázaro Spain 34 2.8k 0.9× 669 0.3× 557 0.7× 668 1.2× 857 1.7× 98 5.8k
Mario Dicato Luxembourg 57 5.1k 1.5× 1.1k 0.5× 1.6k 2.1× 999 1.9× 740 1.5× 219 10.8k
Meiyu Geng China 48 5.3k 1.6× 1.6k 0.8× 1.4k 1.8× 1.1k 2.1× 396 0.8× 295 8.7k
Liping Lin China 40 2.1k 0.6× 1.1k 0.5× 990 1.3× 355 0.7× 332 0.7× 177 4.4k
Dongmei Zhang China 43 3.5k 1.1× 628 0.3× 872 1.1× 892 1.7× 661 1.3× 202 6.3k
Chin‐Chung Wu Taiwan 42 2.5k 0.7× 955 0.5× 298 0.4× 437 0.8× 555 1.1× 191 6.3k
Ramakrishna Sistla India 54 3.1k 0.9× 1.2k 0.6× 689 0.9× 301 0.6× 675 1.4× 189 8.1k
Xi Zheng China 42 2.9k 0.9× 572 0.3× 561 0.7× 915 1.7× 683 1.4× 203 6.5k

Countries citing papers authored by Li Zhang

Since Specialization
Citations

This map shows the geographic impact of Li Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Zhang more than expected).

Fields of papers citing papers by Li Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Zhang. The network helps show where Li Zhang may publish in the future.

Co-authorship network of co-authors of Li Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Li Zhang. A scholar is included among the top collaborators of Li Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Zhang. Li Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chu, Yuan, et al.. (2024). STK3 kinase activation inhibits tumor proliferation through FOXO1-TP53INP1/P21 pathway in esophageal squamous cell carcinoma. Cellular Oncology. 47(4). 1295–1314. 2 indexed citations
3.
Xiang, Min, Lei Fan, Qian Xu, et al.. (2024). Formation of triarylphosphines via P H/C F cross coupling reactions catalyzed by nickel. Tetrahedron Letters. 155. 155445–155445. 2 indexed citations
4.
Zhang, Li, et al.. (2024). Static magnetic field increases the antioxidant stress ability of static cold storage livers and improves post-storage quality. Cell Reports Physical Science. 5(11). 102247–102247. 1 indexed citations
5.
Tan, Jiaqi, Juan Zhang, Juan Zhao, et al.. (2023). Emerging role of HJURP as a therapeutic target in cancers. SHILAP Revista de lepidopterología. 2(2). 5 indexed citations
6.
Zhang, Li, et al.. (2022). Panax notoginseng saponins improves healing of high glucose‐induced wound through the GSK‐3β/β‐catenin pathway. Environmental Toxicology. 37(8). 1867–1877. 17 indexed citations
7.
Xie, Bo, et al.. (2022). Single and combined 1064 nm Q‐switched Nd: YAG laser therapy in melasma: A meta‐analysis. Journal of Cosmetic Dermatology. 21(9). 3794–3802. 4 indexed citations
8.
Wang, Xiaoxiao, Si Zhang, Pingping Dong, et al.. (2021). MRCKβ links Dasm1 to actin rearrangements to promote dendrite development. Journal of Biological Chemistry. 296. 100730–100730. 3 indexed citations
9.
Li, Chunlin, Li Zhang, Yanqi Dang, et al.. (2021). Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology. Biomedicine & Pharmacotherapy. 143. 112181–112181. 25 indexed citations
10.
Zhang, Li, Tao Jiang, Jialu Zhang, et al.. (2021). Efficacy and Safety of Ejiao (Asini Corii Colla) in Women With Blood Deficient Symptoms: A Randomized, Double-Blind, and Placebo-Controlled Clinical Trial. Frontiers in Pharmacology. 12. 718154–718154. 18 indexed citations
11.
12.
Shan, Xiu, Weijie Dong, Li Zhang, et al.. (2020). Role of fucosyltransferase IV in the migration and invasion of human melanoma cells. IUBMB Life. 72(5). 942–956. 8 indexed citations
14.
Cai, Yiran, Hongbo Wu, Xiaoqin Shi, et al.. (2020). Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression. BMC Cancer. 20(1). 148–148. 6 indexed citations
15.
Zhang, Li, Yaohe Wang, Chao Zhao, et al.. (2019). High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Zhang, Mengna, et al.. (2019). Phytochemical screening and analysis of amino acids of Magnolia officinalis seeds. 4(1). 1–5. 1 indexed citations
17.
Gage, Julia C., Pere Gascón, Rajnish Nagarkar, et al.. (2017). P2.06-033 Long-Term Safety and Efficacy of Darbepoetin Alfa in Subjects with Advanced Stage NSCLC Receiving Multi-Cycle Chemotherapy. Journal of Thoracic Oncology. 12(1). S1091–S1092. 1 indexed citations
18.
Zhang, Li, et al.. (2014). Quality Control of Danggui Buxue Tang, a Traditional Chinese Medicine Decoction, by  1H‐NMR Metabolic Profiling. Evidence-based Complementary and Alternative Medicine. 2014(1). 567893–567893. 16 indexed citations
19.
Wang, Hanping, Li Zhang, Fenlai Tan, et al.. (2011). Phase I trial of icotinib, a novel epidermal growth factor receptor tyrosine kinase inhibitor, in Chinese patients with non-small cell lung cancer.. PubMed. 124(13). 1933–1933. 31 indexed citations
20.
Cui, Daxiang, et al.. (2000). Cloning of gcys-18 overexpressed in Chinese gastric carcinoma and its clinical significance. World Journal of Gastroenterology. 6. 45–45. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026